borjatriol

7,14,15-trihydroxy-13-epoxylabdane

CAS: 52591-03-4 C20 H36 O4 MW: 340.50372000

Identification

Nameborjatriol
IUPAC(1R)-1-[(3R,4aS,5S,6aS,10aS,10bR)-5-hydroxy-3,4a,7,7,10a-pentamethyl-2,5,6,6a,8,9,10,10b-octahydro-1H-benzo[f]chromen-3-yl]ethane-1,2-diol
CAS Number52591-03-4
FDA UNIISearch
Molecular FormulaC20 H36 O4
Molecular Weight340.50372000
Nikkaji NumberJ9.953H

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 472.00 to 473.00 °C. @ 760.00 mm Hg (est)
Flash Point 463.00 °F. TCC ( 239.30 °C. ) (est)
logP (o/w) 3.276 (est)
Soluble in alcohol
Insoluble in water

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorynatural substances and extractives
Recommendation for borjatriol usage levels up tonot for fragrance use.
Recommendation for borjatriol flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

None Found

Natural Occurrence

sideritis mugronensis sideritis tragoriganum

Synonyms

(1R)-1-[(3R,4aS,5S,6aS,10aS,10bR)-5- hydroxy-3,4a,7,7,10a-pentamethyl-2,5,6,6a,8,9,10,10b-octahydro-1H-benzo[f]chromen-3-yl]ethane-1,2-diol 7,14,15- trihydroxy-13-epoxylabdane PubMed: Effect of borjatriol on nystatin oedema. PubMed: An approach to the antiinflammatory activity of borjatriol. PubMed: An approach to the antiinflammatory activity of borjatriol. PubMed: Effect of borjatriol on established adjuvant arthritis.